tiprankstipranks
Trending News
More News >
Sau San Tong Holdings Limited (HK:8200)
:8200
Hong Kong Market
Advertisement

Sau San Tong Holdings Limited (8200) AI Stock Analysis

Compare
0 Followers

Top Page

HK:8200

Sau San Tong Holdings Limited

(8200)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - 4o)
Rating:42Neutral
Price Target:
HK$0.50
▼(-12.28% Downside)
Sau San Tong Holdings Limited's overall stock score is primarily impacted by its weak financial performance, characterized by declining revenues and negative profitability. The technical analysis provides mixed signals, with some bearish momentum indicators. Valuation is poor due to the negative P/E ratio and lack of dividend yield, further weighing down the stock's attractiveness.

Sau San Tong Holdings Limited (8200) vs. iShares MSCI Hong Kong ETF (EWH)

Sau San Tong Holdings Limited Business Overview & Revenue Model

Company DescriptionSau San Tong Holdings Limited, an investment holding company, engages in the distribution and sale of cosmetic and skin care products. It also provides beauty and slimming services, such as whole and partial body slimming, weight management, body treatment, and facial treatment services through its slimming centers operated under the Sau San Tong and IPRO brands. In addition, the company is involved in the sale of other health and beauty products; property holding; money lending; and investment in securities. Further, it offers management consultancy, advertising agency, and franchise services; and a proprietary internet platform to promote and sell slimming beauty, and health related services and products. The company operates five beauty and slimming centers in Hong Kong. Sau San Tong Holdings Limited was founded in 2000 and is headquartered in Central, Hong Kong.
How the Company Makes MoneySau San Tong Holdings Limited generates revenue through multiple channels within the traditional Chinese medicine market. The primary revenue stream comes from the sale of TCM products, which includes a wide range of herbal medicines, dietary supplements, and related health products. The company also engages in direct sales and distribution through retail outlets and online platforms, expanding its market reach. Additionally, Sau San Tong may benefit from partnerships with healthcare professionals and wellness centers that promote its products. Factors contributing to its earnings include the growing consumer interest in alternative medicine, increasing health consciousness, and the company's ability to maintain product quality and compliance with health regulations.

Sau San Tong Holdings Limited Financial Statement Overview

Summary
Sau San Tong Holdings Limited faces significant financial challenges with declining revenues and persistent profitability issues. Negative profit margins and returns on equity, coupled with negative cash flow trends, indicate potential liquidity concerns. Despite a low debt-to-equity ratio, the company needs to address operational inefficiencies and improve cash generation.
Income Statement
35
Negative
Sau San Tong Holdings Limited has experienced declining revenue over recent years, with a negative revenue growth rate of -2.37% in the latest year. The company has consistently reported negative net profit margins, indicating ongoing profitability challenges. Gross profit margins have also decreased, reflecting potential issues in cost management or pricing strategy. The EBIT and EBITDA margins are negative, highlighting operational inefficiencies.
Balance Sheet
55
Neutral
The company's balance sheet shows a low debt-to-equity ratio of 0.0186, suggesting conservative leverage and low financial risk. However, the return on equity is negative, indicating that the company is not generating sufficient returns on shareholders' equity. The equity ratio is relatively stable, reflecting a solid equity base compared to total assets.
Cash Flow
30
Negative
Cash flow analysis reveals significant challenges, with negative operating and free cash flows in the latest year. The free cash flow growth rate is highly negative, indicating deteriorating cash generation capabilities. The operating cash flow to net income ratio is negative, suggesting that the company is struggling to convert its earnings into cash.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.06B840.02M1.09B1.23B1.56B1.79B
Gross Profit66.40M49.60M104.57M99.12M137.17M144.49M
EBITDA-40.90M-31.15M6.59M9.90M41.94M21.82M
Net Income-59.81M-51.98M-14.30M-13.93M8.95M-26.42M
Balance Sheet
Total Assets770.90M770.90M843.36M901.34M961.20M982.77M
Cash, Cash Equivalents and Short-Term Investments419.43M419.43M492.91M523.28M529.27M537.96M
Total Debt13.26M13.26M9.53M5.44M6.59M11.53M
Total Liabilities81.28M81.28M87.35M125.64M141.19M174.49M
Stockholders Equity714.66M714.66M770.03M789.65M807.44M800.28M
Cash Flow
Free Cash Flow-26.17M-26.17M-11.23M23.10M-18.13M44.62M
Operating Cash Flow-25.05M-25.05M-5.55M41.13M-5.70M47.28M
Investing Cash Flow378.00K378.00K-5.64M-17.84M-12.05M22.05M
Financing Cash Flow-21.27M-21.27M-9.36M-29.84M-20.74M-13.66M

Sau San Tong Holdings Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.57
Price Trends
50DMA
0.61
Negative
100DMA
0.55
Positive
200DMA
0.49
Positive
Market Momentum
MACD
>-0.01
Negative
RSI
46.78
Neutral
STOCH
52.18
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8200, the sentiment is Negative. The current price of 0.57 is below the 20-day moving average (MA) of 0.57, below the 50-day MA of 0.61, and above the 200-day MA of 0.49, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 46.78 is Neutral, neither overbought nor oversold. The STOCH value of 52.18 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8200.

Sau San Tong Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
62
Neutral
HK$363.93M6.4010.92%11.10%-4.38%
56
Neutral
HK$664.25M21.933.92%-0.92%-71.88%
52
Neutral
HK$119.00M18.032.37%3.51%-1.65%230.00%
48
Neutral
HK$70.51M-8.59%-1.48%-16.04%
42
Neutral
HK$44.94M-7.00%-23.13%-263.65%
41
Neutral
$1.08B-12.38%39.29%-71.82%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8200
Sau San Tong Holdings Limited
0.53
-0.03
-5.36%
HK:0157
Natural Beauty Bio-Technology
0.54
0.05
10.20%
HK:1259
Prosperous Future Holdings
0.03
-0.02
-40.74%
HK:2023
China Ludao Technology Co. Ltd.
0.75
-0.23
-23.47%
HK:3332
Nanjing Sinolife United Co., Ltd. Class H
0.41
-0.23
-35.94%
HK:8281
China Golden Classic Group Ltd.
0.12
<0.01
9.09%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 07, 2025